-
Something wrong with this record ?
Analysis of synapsin III-196 promoter mutation in schizophrenia and bipolar disorder
HM Lachman, P Stopkova, DF Papolos, E Pedrosa, B Margolis, MR Aghalar, T Saito
Language English Country Switzerland
Grant support
NR8564
MZ0
CEP Register
Digital library NLK
Full text - Article
Source
NLK
Karger Journals
from 1998-01-01 to 2009
ProQuest Central
from 1998-08-01 to 2015-12-31
Medline Complete (EBSCOhost)
from 1998-01-01 to 1 year ago
Health & Medicine (ProQuest)
from 1998-08-01 to 2015-12-31
Psychology Database (ProQuest)
from 1998-08-01 to 2015-12-31
PubMed
16511335
Knihovny.cz E-resources
BACKGROUND: The 22q13-linked gene synapsin III is a positional candidate gene for schizophrenia (SZ). One interesting synapsin III single nucleotide polymorphism (SNP), -196G/A, has been identified in the promoter region. The -196A allele results in a 6/8 base match to the core recognition octamer sequence for Oct-1, a member of the POU family of transcription factors. OBJECTIVE: To determine whether or not the -196 SNP is associated with either SZ or bipolar disorder (BD). METHODS: A case control comparison was used to determine whether or not differences in allele or genotype distribution occurred in patients with SZ and BD. Electromobility gel shift assay (EMSA) was used to determine whether the -196 SNP affected protein binding. RESULTS: A trend towards significance was detected when the allele distribution was analyzed in Caucasian patients with SZ (n = 145; 191 controls) and a cohort of subjects from the Czech Republic with BD (n = 82; 94 controls). No association was found in bipolar patients from the United States (n = 127) or in African-American patients with SZ (n = 124; 133 controls). EMSA showed that the region encompassing the -196 SNP binds to a brain protein in an allele-specific manner. CONCLUSIONS: These data, while inconclusive, suggest that -196 SNP should be further investigated as a candidate for 22q13-linked SZ. 2006 S. Karger AG, Basel
Literatura
- 000
- 00000naa a2200000 a 4500
- 001
- bmc14066045
- 003
- CZ-PrNML
- 005
- 20190104111912.0
- 007
- ta
- 008
- 140722s2006 sz f 000 0|eng||
- 009
- AR
- 035 __
- $a (PubMed)16511335
- 040 __
- $a ABA008 $d ABA008 $e AACR2 $b cze
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Lachman, Herbert M. $u Department of Psychiatry and Behavioral Sciences, Division of Psychiatry Research, Albert Einstein College of Medicine, Bronx, NY 10461, USA. Lachman@aecom.yu.edu
- 245 10
- $a Analysis of synapsin III-196 promoter mutation in schizophrenia and bipolar disorder / $c HM Lachman, P Stopkova, DF Papolos, E Pedrosa, B Margolis, MR Aghalar, T Saito
- 504 __
- $a Literatura
- 520 9_
- $a BACKGROUND: The 22q13-linked gene synapsin III is a positional candidate gene for schizophrenia (SZ). One interesting synapsin III single nucleotide polymorphism (SNP), -196G/A, has been identified in the promoter region. The -196A allele results in a 6/8 base match to the core recognition octamer sequence for Oct-1, a member of the POU family of transcription factors. OBJECTIVE: To determine whether or not the -196 SNP is associated with either SZ or bipolar disorder (BD). METHODS: A case control comparison was used to determine whether or not differences in allele or genotype distribution occurred in patients with SZ and BD. Electromobility gel shift assay (EMSA) was used to determine whether the -196 SNP affected protein binding. RESULTS: A trend towards significance was detected when the allele distribution was analyzed in Caucasian patients with SZ (n = 145; 191 controls) and a cohort of subjects from the Czech Republic with BD (n = 82; 94 controls). No association was found in bipolar patients from the United States (n = 127) or in African-American patients with SZ (n = 124; 133 controls). EMSA showed that the region encompassing the -196 SNP binds to a brain protein in an allele-specific manner. CONCLUSIONS: These data, while inconclusive, suggest that -196 SNP should be further investigated as a candidate for 22q13-linked SZ. 2006 S. Karger AG, Basel
- 590 __
- $a bohemika - dle Pubmed
- 650 02
- $a African Americans $x ge [Genetics]
- 650 02
- $a Analysis of Variance
- 650 02
- $a Bipolar Disorder $x eh [Ethnology]
- 650 12
- $a Bipolar Disorder $x ge [Genetics]
- 650 02
- $a Case-Control Studies
- 650 02
- $a Chi-Square Distribution
- 650 12
- $a Chromosomes, Human, Pair 22 $x ge [Genetics]
- 650 02
- $a European Continental Ancestry Group $x ge [Genetics]
- 650 02
- $a Gene Frequency $x ge [Genetics]
- 650 02
- $a Genetic Linkage
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a Neuropeptides $x ge [Genetics]
- 650 02
- $a Neuropeptides $x me [Metabolism]
- 650 12
- $a Phosphoproteins $x ge [Genetics]
- 650 02
- $a Phosphoproteins $x me [Metabolism]
- 650 02
- $a Polymorphism, Single Nucleotide $x ge [Genetics]
- 650 12
- $a Promoter Regions, Genetic $x ge [Genetics]
- 650 02
- $a Protein Binding $x ge [Genetics]
- 650 02
- $a Schizophrenia $x eh [Ethnology]
- 650 12
- $a Schizophrenia $x ge [Genetics]
- 650 02
- $a Statistics, Nonparametric
- 650 02
- $a Synapsins
- 700 1_
- $a Stopková, Pavla, $d 1971- $7 mzk2008430635 $u Psychiatric Center, Prague, Czech Republic
- 700 1_
- $a Papolos, Demitri F. $u Department of Psychiatry and Behavioral Sciences, Division of Psychiatry Research, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
- 700 1_
- $a Pedrosa, Erika $u Department of Psychiatry and Behavioral Sciences, Division of Psychiatry Research, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
- 700 1_
- $a Margolis, Benjamin $u Department of Psychiatry and Behavioral Sciences, Division of Psychiatry Research, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
- 700 1_
- $a Aghalar, Maryam Rafael $u Department of Psychiatry and Behavioral Sciences, Division of Psychiatry Research, Albert Einstein College of Medicine, Bronx, NY 10461, USA. $7 gn_A_00002162
- 700 1_
- $a Saito, Takuya $u Department of Psychiatry and Behavioral Sciences, Division of Psychiatry Research, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
- 773 0_
- $t Neuropsychobiology $x 0302-282X $g Roč. 53, č. 2 (2006), s. 57-62 $p Neuropsychobiology $w MED00003499
- 773 0_
- $p Neuropsychobiology $g 53(2):57-62, 2006 $x 0302-282X
- 910 __
- $a ABA008 $b B 1561 $y 4 $z 0
- 990 __
- $a 20140722121513 $b ABA008
- 991 __
- $a 20190104112107 $b ABA008
- 999 __
- $a ok $b bmc $g 1033478 $s 864821
- BAS __
- $a 3
- BMC __
- $a 2006 $b 53 $c 2 $d 57-62 $i 0302-282X $m Neuropsychobiology $x MED00003499
- GRA __
- $a NR8564 $p MZ0
- LZP __
- $a 2014-07/ewbo